151 – 160 of 211
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
(
- Contribution to journal › Article
-
Mark
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
(
- Contribution to journal › Article
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
-
Mark
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
(
- Contribution to journal › Article
- 2012
-
Mark
Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
(
- Contribution to journal › Article
-
Mark
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.
(
- Contribution to journal › Article
-
Mark
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Metal-on-metal joint bearings and hematopoetic malignancy A review
(
- Contribution to journal › Scientific review
-
Mark
A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers
(
- Contribution to journal › Article